Related Experiment Video
Updated: Aug 22, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
The ethical use of placebo in clinical trials involving children
Albert T Derivan1, Bennett L Leventhal, John March
1Pediatric Drug Development, Johnson & Johnson Pharmaceutical Research & Development, Philadelphia, PA, USA. doc@derivan.org
Insights
Ethical guidelines for placebo-controlled trials in minors need updating. A multidisciplinary working group should review and expand current pediatric research ethics, focusing on placebo use in drug evaluations.
Area of Science:
- Pediatric Research Ethics
- Clinical Trial Design
- Bioethics
Background:
- Current ethical guidelines for placebo-controlled trials in minors are insufficient.
- The American Academy of Pediatrics (AAP) guidelines from 1995 require review.
- Ethical considerations in pediatric drug studies are complex.
Purpose of the Study:
- To review existing statements on ethical placebo use in pediatric clinical trials.
- To propose an expansion of current ethical guidelines.
- To advocate for an updated framework for placebo-controlled trials in children.
Main Methods:
- Review of key ethical documents and statements.
- Analysis of the AAP's "Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations" (1995).
- Identification of areas for guideline expansion.
Main Results:
- Existing guidelines for placebo use in pediatric trials need enhancement.
- A comprehensive review of ethical considerations is necessary.
- Current frameworks may not fully address the complexities of pediatric placebo-controlled studies.
Conclusions:
- There is a need to update and expand ethical guidelines for placebo-controlled trials involving minors.
- A collaborative working group is recommended for this update.
- Stakeholder involvement is crucial for developing robust pediatric research ethics.
Abstract:
The authors reviewed various statements describing the ethical use of placebo-controls in clinical trials involving minors. Attention was focused upon the Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations, published by the American Academy of Pediatrics (AAP) (Kaufman et al. 1995). A brief review of certain key documents and a possible expansion of the guidelines are presented. Specifically, it is recommended that a review and update of guidelines for the use of placebo-controlled trials in children be undertaken by a working group comprised of stakeholders, including academic clinical and research professionals, bioethicists, consumers, members of key government agencies, and the pharmaceutical industry.
Related Concept Videos
Blinding
Blind Procedures
The Placebo Effect
Clinical Trials
There are four phases in a clinical trial. A phase one...
Ethics in Research
Clinical Trials: Overview
